Targeting mitochondrial dynamics of morphine-responsive dopaminergic neurons ameliorates opiate withdrawal
Journal of Clinical Investigation · 01.03.2024 · 134 (5)
DOI: 10.1172/jci171995 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 18.01.2024. Verfasst von Changyou Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science and School of Basic Medical Scie…. Hauptthemen laut MEDLINE: Opiate Alkaloids, Substance Withdrawal Syndrome. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: STI2030-Major Projects, CAMS Innovation Fund for Medical Sciences, Shanghai Rising-Star Program.
Abstract (Originalsprache)
Converging studies demonstrate the dysfunction of the dopaminergic neurons following chronic opioid administration. However, the therapeutic strategies targeting opioid-responsive dopaminergic ensembles that contribute to the development of opioid withdrawal remain to be elucidated. Here, we used the neuronal activity-dependent Tet-Off system to label dopaminergic ensembles in response to initial morphine exposure (Mor-Ens) in the ventral tegmental area (VTA). Fiber optic photometry recording and transcriptome analysis revealed downregulated spontaneous activity and dysregulated mitochondrial respiratory, ultrastructure, and oxidoreductase signal pathways after chronic morphine administration in these dopaminergic ensembles. Mitochondrial fragmentation and the decreased mitochondrial fusion gene mitofusin 1 (Mfn1) were found in these ensembles after prolonged opioid withdrawal. Restoration of Mfn1 in the dopaminergic Mor-Ens attenuated excessive oxidative stress and the development of opioid withdrawal. Administration of Mdivi-1, a mitochondrial fission inhibitor, ameliorated the mitochondrial fragmentation and maladaptation of the neuronal plasticity in these Mor-Ens, accompanied by attenuated development of opioid withdrawal after chronic morphine administration, without affecting the analgesic effect of morphine. These findings highlighted the plastic architecture of mitochondria as a potential therapeutic target for opioid analgesic-induced substance use disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science and School of Basic Medical Sciences, Departments of Neurosurgery and Hand Surgery, Huashan Hospital,…
- Research Unit of Addiction Memory, Chinese Academy of Medical Sciences (2021RU009), Shanghai, China.
Förderung
- STI2030-Major Projects
- CAMS Innovation Fund for Medical Sciences
- Shanghai Rising-Star Program
- National Natural Science Foundation of China
- Shanghai Municipal Education Commission “Chenguang program”
Zitieren
APA
Jiang, C., Huang, H., Yang, X., Le, Q., Liu, X., Ma, L., & Wang, F. (2024). Targeting mitochondrial dynamics of morphine-responsive dopaminergic neurons ameliorates opiate withdrawal. Journal of Clinical Investigation, 134(5). https://doi.org/10.1172/jci171995
Vancouver
Jiang C, Huang H, Yang X, Le Q, Liu X, Ma L, et al. Targeting mitochondrial dynamics of morphine-responsive dopaminergic neurons ameliorates opiate withdrawal. Journal of Clinical Investigation. 2024;134(5). doi:10.1172/jci171995
BibTeX
@article{Jiang2024,
author = {Jiang, Changyou and Huang, Han and Yang, Xiao and Le, Qiumin and Liu, Xing and Ma, Lan and Wang, Feifei},
title = {Targeting mitochondrial dynamics of morphine-responsive dopaminergic neurons ameliorates opiate withdrawal},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {5},
doi = {10.1172/jci171995}
}
EUVIMED